Meeting
2013 Genitourinary Cancers Symposium
A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort.
Authors
Matthew R. Cooperberg
University of California, San Francisco, San Francisco, CA
Matthew R. Cooperberg , Anamaria Crisan , Anirban Pradip Mitra , Mercedeh Ghadessi , Christine Buerki , Elai Davicioni
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 60)
DOI
10.1200/jco.2013.31.6_suppl.60
Abstract #
60
Poster Bd #
D15
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Validation of a genomic risk classifier to predict prostate cancer-specific mortality (PCSM) in high-risk patients.
First Author: Jeffrey Karnes
Poster
2015 Genitourinary Cancers Symposium
Validation of the Decipher prostate cancer classifier in intermediate to high-risk men treated with radical prostatectomy but without additional therapy upon PSA rise.
First Author: Ashley Ross
Poster
2021 ASCO Annual Meeting
Validation of the decipher genomic classifier (GC) in SAKK 09/10: A phase III randomized trial of dose-escalated salvage radiotherapy (SRT) after radical prostatectomy (RP).
First Author: Alan Dal Pra
Poster
2019 ASCO Annual Meeting
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative trial in high risk localized prostate cancer (PC).
First Author: Laura Graham